RNA cancer vaccines: developing mRNA nanovaccine with self-adjuvant property for cancer immunotherapy

.

Source: Human Vaccines and Immunotherapeutics - May 4, 2021 Category: Allergy & Immunology Authors: Hongxia Zhang Xiaojun Xia Source Type: research